{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T23:04:59Z","timestamp":1773011099339,"version":"3.50.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,8]]},"DOI":"10.7759\/cureus.104862","type":"journal-article","created":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T21:26:31Z","timestamp":1773005191000},"source":"Crossref","is-referenced-by-count":0,"title":["Olmesartan-Associated Enteropathy With Severe Diarrhoea and Acute Kidney Injury"],"prefix":"10.7759","author":[{"given":"Arina","family":"Nikolaeva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Della Vecchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2012.06.003","article-title":"Severe spruelike enteropathy associated with olmesartan","volume":"87","author":"Rubio-Tapia A","year":"2012","unstructured":"Rubio-Tapia A, Herman ML, Ludvigsson JF, Kelly DG, Mangan TF, Wu TT, Murray JA. Severe spruelike enteropathy associated with olmesartan. Mayo Clin Proc. 2012, 87:732-8. 10.1016\/j.mayocp.2012.06.003","journal-title":"Mayo Clin Proc"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12780","article-title":"Systematic review: sprue-like enteropathy associated with olmesartan","volume":"40","author":"Ianiro G","year":"2014","unstructured":"Ianiro G, Bibb\u00f2 S, Montalto M, Ricci R, Gasbarrini A, Cammarota G. Systematic review: sprue-like enteropathy associated with olmesartan. Aliment Pharmacol Ther. 2014, 40:16-23. 10.1111\/apt.12780","journal-title":"Aliment Pharmacol Ther"},{"key":"ref3","article-title":"The Los Angeles classification of gastroesophageal reflux disease","volume":"1","author":"Sami S","year":"2013","unstructured":"Sami S, Ragunath K. The Los Angeles classification of gastroesophageal reflux disease. Video J Encyc GI Endosc. 2013, 1:103-4.","journal-title":"Video J Encyc GI Endosc"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/bs.podrm.2017.02.005","article-title":"Olmesartan","volume":"42","author":"Al-Majed AA","year":"2017","unstructured":"Al-Majed AA, Bakheit AH, Abdel Aziz HA, Al-Jallal AA. Olmesartan. Profiles Drug Subst Excip Relat Methodol. 2017, 42:241-86. 10.1016\/bs.podrm.2017.02.005","journal-title":"Profiles Drug Subst Excip Relat Methodol"},{"key":"ref5","unstructured":"FDA Drug Safety Communication. FDA approves label changes to include intestinal problems (sprue-like enteropathy) linked to blood pressure medicine olmesartan medoxomil. (2013). Accessed: January 22, 2026: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-approves-label-changes-inclu...."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14518","article-title":"Use of olmesartan and enteropathy outcomes: a multi-database study","volume":"47","author":"Dong YH","year":"2018","unstructured":"Dong YH, Jin Y, Tsacogianis TN, He M, Hsieh PH, Gagne JJ. Use of olmesartan and enteropathy outcomes: a multi-database study. Aliment Pharmacol Ther. 2018, 47:792-800. 10.1111\/apt.14518","journal-title":"Aliment Pharmacol Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000002208","article-title":"An unusual cause of diarrhoea: case report and literature review of olmesartan-associated enteropathy","volume":"33","author":"Mauloni PA","year":"2021","unstructured":"Mauloni PA, Capuani F, Paone C, et al.. An unusual cause of diarrhoea: case report and literature review of olmesartan-associated enteropathy. Eur J Gastroenterol Hepatol. 2021, 33:e1060-6. 10.1097\/MEG.0000000000002208","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1159\/000538552","article-title":"Severe hepatitis complicating olmesartan enteropathy: a case report","volume":"18","author":"Tan R","year":"2024","unstructured":"Tan R, Abasszade JH, Dhillon H, Kuan CC, Worland T, Tabatabai S. Severe hepatitis complicating olmesartan enteropathy: a case report. Case Rep Gastroenterol. 2024, 18:238-43. 10.1159\/000538552","journal-title":"Case Rep Gastroenterol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.36660","article-title":"Olmesartan-induced ischemic enteritis complicated with bowel perforation: a case report and literature review","volume":"15","author":"Alexander D","year":"2023","unstructured":"Alexander D, Abdelazeem B, Alnounou M. Olmesartan-induced ischemic enteritis complicated with bowel perforation: a case report and literature review. Cureus. 2023, 15:e36660. 10.7759\/cureus.36660","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309690","article-title":"Severe intestinal malabsorption associated with olmesartan: a French nationwide observational cohort study","volume":"65","author":"Basson M","year":"2016","unstructured":"Basson M, Mezzarobba M, Weill A, Ricordeau P, Allemand H, Alla F, Carbonnel F. Severe intestinal malabsorption associated with olmesartan: a French nationwide observational cohort study. Gut. 2016, 65:1664-9. 10.1136\/gutjnl-2015-309690","journal-title":"Gut"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.20524\/aog.2016.0052","article-title":"Small bowel enteropathy associated with olmesartan medoxomil treatment","volume":"30","author":"Galanopoulos M","year":"2017","unstructured":"Galanopoulos M, Varytimiadis L, Tsigaridas A, et al.. Small bowel enteropathy associated with olmesartan medoxomil treatment. Ann Gastroenterol. 2017, 30:131-3. 10.20524\/aog.2016.0052","journal-title":"Ann Gastroenterol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/465389-olmesartan-associated-enteropathy-with-severe-diarrhoea-and-acute-kidney-injury","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T21:26:32Z","timestamp":1773005192000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/465389-olmesartan-associated-enteropathy-with-severe-diarrhoea-and-acute-kidney-injury"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,8]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.104862","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,8]]}}}